@ participants were randomly allocated to the FOLFOX group and @ to the fluorouracil and cisplatin group ( intention-to-treat population ) , and @ patients in the FOLFOX group and @ in the fluorouracil and cisplatin group actually received the study drugs ( safety population ) .